PJ DiPentino made the seven-hour trek from his home in Montana to Huntsman Cancer Institute. After receiving a warm welcome, he underwent bladder surgery and left with a long-lasting connection.
Read about new melanoma treatment practices, how models provide information about a rare adrenal cancer, a potential oral medication for brain cancer, and clinical trials for cancer patients with HIV.
Each month, we’d like to highlight some current work at Huntsman Cancer Institute. See how a potential new immunotherapy for breast cancer is being developed, learn about research being done...
When Bret Boyle lost his vision while on vacation in Hawaii, he immediately flew home to be treated. His mantle cell lymphoma has returned. Luckily, the FDA had recently approved...
New members added to The Society of Huntsman Translational Scholars. They include Gita Suneja, MD, MS; Siwen Hu-Lieskovan, MD, PhD; and Douglas Sborov, MD, MS.
5 For The Fight, a nonprofit started by Qualtrics and fueled by thousands of private donors, announced today that seven new cancer researchers will get a boost for their work...
Max Rosett faced melanoma as a young adult and a decade later, he is cancer free. He describes how he felt after being diagnosed, the outstanding treatment he received at...
For Siwen Hu-Lieskovan, MD, PhD, it was the promise of immunotherapy—that is, harnessing the body’s own immune system to fight cancer—that inspired her to get into cancer research. Training under...
Siwen Hu-Lieskovan, PhD, MD, physician scientist at Huntsman Cancer Institute and assistant professor of medicine at the University of Utah, has received the National Cancer Institute 2020 Cancer Clinical Investigator...
5 For The Fight, a global movement inviting everyone to give $5 for the fight against cancer, today announced the inaugural recipients of the 5 For The Fight Cancer Research...
Only a few months after she retired in October 2018, Lynn Walker knew something was wrong with her health. Without any prior history of skin cancers, she learned that she...
